T-helper 1 cell activation

T-helper 1 (Th1) cell activation is a complex immunological process characterized by the polarization of naïve CD4+ T cells toward the Th1 phenotype. This process is driven primarily by exposure to interleukin 12 (IL-12) and interferon-gamma (IFN-γ), as well as transcription factors STAT4 and T-bet. Upon activation, Th1 cells secrete IFN-γ and TNF-α, which activate macrophages to kill intracellular pathogens (such as Mycobacterium tuberculosis) and support cytotoxic T cell responses. Th1 activation plays a protective role in defense against intracellular infections and in antitumor immunity, but overactivation contributes to autoimmune and inflammatory diseases such as Type 1 diabetes and delayed-type hypersensitivity. Drugs affecting Th1 responses include cytokine modulators, immunosuppressants, and costimulatory pathway inhibitors. However, Th1 activation itself is not a single molecular target, but a coordinated network of signals and cellular differentiation within the immune system.

Other names

Th1 cell activationT-helper 1 activationTh1 polarization

Enhancement or inhibition of cytokines critical for Th1 differentiation (mainly IL-12, IFN-γ); Blockade or stimulation of co-stimulatory molecules (CD28/B7 pathway; CD40/CD40L interaction); Broad immunosuppression of T-cell activation